RAVI GHANTA to Myocardial Infarction
This is a "connection" page, showing publications RAVI GHANTA has written about Myocardial Infarction.
Connection Strength
2.483
-
Influence of Supraphysiologic Biomaterial Stiffness on Ventricular Mechanics and Myocardial Infarct Reinforcement. Acta Biomater. 2022 09 01; 149:30-39.
Score: 0.434
-
Racial/ethnic differences persist in treatment choice and outcomes in isolated intervention for coronary artery disease. J Thorac Cardiovasc Surg. 2023 10; 166(4):1087-1096.e5.
Score: 0.422
-
Cell-Laden Bioactive Poly(ethylene glycol) Hydrogels for Studying Mesenchymal Stem Cell Behavior in Myocardial Infarct-Stiffness Microenvironments. Cardiovasc Eng Technol. 2021 04; 12(2):183-199.
Score: 0.392
-
Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium. Biomater Sci. 2020 Sep 15; 8(18):5061-5070.
Score: 0.383
-
Commentary: "Shear" patience for post-myocardial infarction regenerative therapy. J Thorac Cardiovasc Surg. 2020 05; 159(5):1836-1837.
Score: 0.352
-
Does Preoperative Troponin Level Impact?Outcomes After Coronary Artery Bypass Grafting? Ann Thorac Surg. 2018 07; 106(1):46-51.
Score: 0.322
-
CRISPR-Cas-based activation of PPARGC1A boosts endogenous mitochondria and enhances cardiac function after myocardial infarction. Mol Ther. 2026 Jun 03; 34(6):3320-3333.
Score: 0.140
-
Successful revascularization of multiple coronary artery aneurysms using a combination of surgical strategies. Ann Thorac Surg. 2007 Aug; 84(2):e10-1.
Score: 0.039